Health Trials

About this trial

Recently a dietary recommendation of 400 - 600 mg/ day has been proposed for the reduced risk of developing cardiovascular disease. Dietary flavanols can be obtained from the intake of foods such as tea, cocoa, wine, berries and apples. Incorporating Chardonnay Marc (the skins and seeds of Chardonnay grapes) into the diet can be an additional source of dietary flavanols. Like other flavanol-rich foods, Chardonnay Marc provides fiber and polysaccharides that may benefit gut health. This study seeks pilot data on the impact of the daily incorporation of Chardonnay Marc powder into the diet on markers of gut and cardiometabolic health.

Eligibility criteria

Qualifiers

Postmenopausal female, with a cessation of menses for at least 2 years

45-70 years of age

BMI 25- 49.9 kg/m2

Fasting triglycerides > 120 mg/dL

Disqualifiers

Self-reported use of daily anticoagulation agents including aspirin, NSAIDs

Prescription medications and supplements, except for a 6 month stable dose of thyroid medications

Vegan, Vegetarians, food faddists or those consuming a non-traditional diet

Fruit consumption ≥ 3 cups/day

Trial design

Treatments tested in this trial

  • Chardonnay Marc

Treatment groups

5 Participants
are divided into 2 treatment groups

Locations

1
University of California, Davis95616, DavisCalifornia, United States

Sponsors and collaborators

University of California, Davis

Lead sponsor

Source ClinicalTrials.gov